Eli Lilly’s $6 billion facility: ‘Merry Christmas and Happy New Year to the city of Huntsville’

The Huntsville Planning Commission voted to rezone 73.40 acres east of Greenbrier Road and north of Interstate 565 in ...

City takes step toward bringing $6 billion Eli Lilly facility to Huntsville

The City of Huntsville has taken another step toward bringing pharmaceutical giant Eli Lilly’s $6 billion facility to the ...

City takes another step toward bringing $6 billion Eli Lilly facility to Huntsville

The City of Huntsville has taken another step toward bringing pharmaceutical giant Eli Lilly’s $6 billion facility to the ...

Eli Lilly, Pfizer Among 19 Drugs Approved for China's Commercial Health Insurance

China approves 19 innovative drugs for commercial health insurance, opening new market opportunities for global and local ...

Eli Lilly's Obesity Drug Dominance Still Underpriced By Market, Bank of America Says

Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as ...
Yahoo Malaysia

Eli Lilly or Merck: Where Should Investors Put Their Money?

LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer ...

Eli Lilly, Pfizer land on China’s first private insurance list

Eli Lilly & Co., Pfizer Inc. and Johnson & Johnson secured spots on China’s first innovative drug catalog, opening a new ...

Pfizer: 2026 Feels Like Another Lost Year After Yesterday's Guidance Update

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

AbbVie, Several Other Pharma Companies Near MFN Deal With Trump, Sources Say

So far five companies have agreed to the terms. They are Pfizer, Eli ​Lilly, AstraZeneca, Novo Nordisk and EMD Serono, which ...

COMMENTARY: The real story behind Trump’s GLP-1 price cut: Markets still rule

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...
Fierce Pharma

Meds from Pfizer, Lilly, J&J and more secure spots in China's 1st private insurance formulary

Nineteen novel drugs have been selected for inclusion in the first iteration of China's Commercial Health Insurance Innovative Drug Catalogue, portending potential access benefits as the program ga | ...